Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non-profit company that emerges will develop and distribute opioid use ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...

Third-party releases may no longer provide a shield to owners and directors of a reorganized company. Still, a New York bankruptcy court ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic collaboration. Purdue University is on the forefront of Pharma 4.0 by partnering ...

Please send tips or suggestions to D.Thomas@thomsonreuters.com, opens new tab) Purdue Pharma's bankruptcy entered ... Purdue's wealthy Sackler family owners from civil liability.

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...

North Carolina was among 15 states to reach the $7.4 billion settlement in January with Purdue Pharma and its owners, the Sackler family, for their alleged culpability in the national opioid crisis.

Purdue Pharma filed a new bankruptcy plan on Tuesday ... The headline figure had been previously flagged by Purdue and its owners, members of the wealthy Sackler family. The formal bankruptcy ...

Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners, nearly two months after agreeing to a $7.4bn opioid settlement.